With reports that industries worldwide could save $437 billion per year by 2030 by improving energy efficiency alone, sustainability initiatives continue to be a driving force behind the evolution of business process and technological development. In this webinar on 9/12, we will explore achievements in the areas of sustainability, outlining the strategies, partnerships and technology tools that have driven recent success. 📅 Reserve your spot: https://lnkd.in/d6rA7Kzb 🗣 Speakers: Guido D´Agostino, Head of Global Procurement, Chiesi Group Stefan Dürr, Senior Director, Product Management and Client Delivery, IQVIA IRT
Clinical Leader
Pharmaceutical Manufacturing
Erie, Pennsylvania 14,485 followers
A resource and forum to investigate and resolve the common struggles related to running effective clinical trials.
About us
The landscape of the life sciences industry is as vast and varied as the professionals who work in it. Some online resources aim to serve the entire space. We wish them luck. Instead, our goal is to be the most valuable resource for a specific segment of the industry – clinical research & trials – and the professionals who make their living there. The Clinical Leader community is not made up of generalists. They’re specialists, like us. We deliver in-depth content from authoritative authors and sources because that’s what our community demands. Our editors connect with and interview top clinical executives from pharmaceutical and biotech companies who share best practices, challenges faced and overcome, clinical trends, partnering strategies, and experiences implementing new technologies. Additionally, our Clinical Leader Live series of live events provides an interactive forum where sponsor companies talk about some of today's biggest challenges when managing clinical trials. Even better, the audience gets to ask questions during the presentation.
- Website
-
https://www.clinicalleader.com/
External link for Clinical Leader
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Erie, Pennsylvania
- Founded
- 1995
- Specialties
- Clinical Trials and CRO
Updates
-
The FDA has until October 1, 2024 to respond to a number of questions regarding concerns about clinical trials being conducted in The People's Republic of China. How will their answers affect trials going forward and the sponsors that were conducting those China-based trials? https://lnkd.in/d_6veA8E By Dan Schell, Chief Editor, Clinical Leader
-
VIRTUAL EVENT TOMORROW! Watch our Clinical Leader Live discussion on 9/5, where our expert panel will discuss what’s good and bad regarding the new #FDA Guidance and what's currently working to improve the representation of age, sex, racial, and ethnic demographic characteristics in trials today. 📅 Reserve your spot: https://lnkd.in/dViYiF8u
-
-
Join us next week for a deep dive into IQVIA eCOA: https://lnkd.in/e-aKw7Tw In this webinar, IQVIA eCOA expert Edward Bartels will provide an overview of the eCOA landscape, discussing where the market is, where it's going, and what IQVIA eCOA has to offer. He will then give a demo of the IQVIA eCOA platform, focusing in on: ◽ How to effortlessly create a diary ◽ Scheduling site/participant assessments ◽ Managing translations and compliance ◽ And so much more!
-
-
In this week's issue, we'll explore what clinical trial information VCs and investors actually want, the importance of a robust data strategy, how to mitigate financial risk before partnering with a CRO, the benefits of managed competitive enrollment, and other popular insights! Artem A. Trotsyuk, Sergey Jakimov, Artemy Shumskiy, Vlad C., LongeVC | Dana Vanderwall, Andy Newell, ProPharma | Dan Schell | inSeption Group | Norman Goldfarb | Shontelle Dodson, Astellas Pharma | Allan Gibson, Bill & Melinda Gates Medical Research Institute | Veeva Systems
The Clinical Trial Information VCs And Investors Actually Want, The Importance of Data Strategy, and More
Clinical Leader on LinkedIn
-
Heading Merck’s INTerpath-005 Phase 2 trial for muscle-invasive urothelial carcinoma, a type of cancer found in the bladder or upper urinary tract, AdventHealth's Guru Sonpavde, MD credits the patient-centric trial design, Orlando, Florida's diversity, and the staff’s expertise with trial execution for giving bladder cancer patients a chance at a quicker and fuller recovery. https://lnkd.in/e5wFYtBv
A Perfect Pair? Combining Keytruda And mRNA Therapy To Optimize Bladder Cancer Outcomes
clinicalleader.com
-
Small and emerging biopharma has surged to the forefront of oncology development, comprising 70% of 2023 trial starts according to IQVIA Institute for Human Data Science. With young, innovative, funding-conscious companies leading the charge, experienced trial partners are pivotal to commercial and patient success. On September 25th, the Clinical Leader Solutions Expo: Early Phase Oncology will bring together an array of industry leaders and niche experts from CROs who will share their capabilities in guiding small and emerging biopharma through these complex trials. Reserve your spot for the virtual expo: https://lnkd.in/eSMG2Xb6 Presenters Include: Avance Clinical IQVIA Biotech Parexel ProPharma Worldwide Clinical Trials Expo sponsored by Cerba Research
-
-
Psilocybin and DMT are both considered Schedule I drugs by the DEA. Yet, clinical-stage biopharmaceutical company Cybin Inc is looking to develop drugs in both categories with its CYB003 and CYB004 clinical programs. CEO Doug Drysdale discusses regulatory considerations relating to the pursuit of two different psychedelic drugs and talks about trends in the larger psychedelic drug space. https://lnkd.in/eHXDBUNk
FDA Talks Help Cybin Advance Two Psychedelic Drugs Toward Approval
clinicalleader.com
-
VIRTUAL EVENT NEXT WEEK! Watch our Clinical Leader Live discussion on 9/5, where our expert panel will discuss what’s good and bad regarding the new #FDA Guidance and what's currently working to improve the representation of age, sex, racial, and ethnic demographic characteristics in trials today. 📅 Reserve your spot: https://lnkd.in/emHNpuMT
-
-
Clinical Leader reposted this
Don't miss this one! It's shaping up to be one of our most popular live events of the year. Register today at https://lnkd.in/gnzQasfB #diversityinclinicaltrials #clinicaltrialdesign
-